|
Reference #:
2002-017
Inventors/Contributors
Esteban Celis, M.D.
Description
A promiscuous T cell peptide epitope from the EBNA2 antigen has been identified. T cells induced with this epitope are capable of recognizing cells infected and transformed with the Epstein Barr virus (EBV). Mayo researchers have developed a vaccine using this epitope in the form of a synthetic peptide, to induce or enhance immunity against EBV. This vaccine could be tested in transplant patients, which are highly susceptible to EBV infections and EBV-induced malignancies.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
